|SEARCH | GIVING TO NU | NU HOME|
New Bradstreet Chair Advances Biotech Initiative
The biotech program, a key focus of the Leadership Campaign, is pairing the university's strengths in biology, physics, chemistry, engineering, and computer science with industry's fast-growing demand for products ranging from pharmaceuticals to computer technology.
The program is closely affiliated with the Barnett Institute, which is world renowned for research and training in analytical chemistry and biotechnology.
"The twenty-first century will be the biotechnology age," predicts Edward Jarroll, special assistant to the provost for biotechnology.
"With long-standing strengths in the sciences and engineering, Northeastern is poised to be at the forefront of this emerging field. Dr. Hancock is an important addition to our efforts."
Hancock will establish a research program in clinical proteomics, the study of proteins in diseases.
"Proteomics is likely to have a far-reaching impact on society, as it may someday help doctors create more personalized treatment for illnesses," says Barry Karger, director of the Barnett Institute.
A native of Australia, Hancock has held distinguished positions at Yale University, the U.S. Food and Drug Administration, and Thermo Finnigan Corporation. Hancock holds ten patents, and has published seven books and over 150 scientific articles.
The Bradstreet Chair was made possible by the generous bequest of the late Raymond B. Bradstreet, H'88.
Other recent steps in the biotech initiative include
an interdisciplinary faculty appointment in bioinformatics; the Gene-Chip
Institute, established last year to promote geonomics research; and
a new master's degree program in bioinformatics, offered in conjunction
with Boston University. A search is also under way to fill the George
Behrakis Trustee Professorship, based in Bouvé College of Health
|This article was printed in the March 2003 issue of Northeastern University Magazine.|
Copyright © 2006 Northeastern University. All rights